Results · Apr-Jun 2026 · filed 13 Aug 2026
Max Healthcare Institute Q1 FY27 results
Sales grew 17% to ₹2,366 crore from ₹2,028 crore in Apr-Jun 2025.
Operating profit grew 14% to ₹598 crore, an operating margin of 25.3% (down 0.5 points from a year ago).
Net profit grew 5% to ₹323 crore from ₹308 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +10%, net profit −6%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 2,366 | 2,028 | +17% |
| Operating profit (EBITDA) | 598.4 | 522.9 | +14% |
| Operating margin | 25.3% | 25.8% | −0.5 pts |
| Net profit | 323.0 | 308.0 | +5% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The earnings call
Max Healthcare reported 16% revenue growth & 15% operating EBITDA growth in Apr–Jun 2026. The company is expanding capacity across multiple hospitals, entered medical education with board approval & acquired Bhubaneswar hospital with significant turnaround potential.
The last 7 quarters
Filings that week
- 19 Aug 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- 17 Aug 2026Announcement under Regulation 30 (LODR)-Investor Presentation
- 14 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 14 Aug 2026Audio Recording Of Earnings Call Held On August 14, 2026
- 14 Aug 2026Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Change in Management
- 13 Aug 2026Presentation On Earnings Update
- 13 Aug 2026Announcement under Regulation 30 (LODR)-Press Release / Media Release
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.